A groundbreaking shift in our drug policy has occurred, as the government permit the legalization of psilocybin mushrooms for therapeutic applications. Before this, these substances were strictly restricted, but a increasing body of evidence suggests they potentially offer relief for emotional illnesses like anxiety. The new policy represents a maj